JP2023505441A5 - - Google Patents
Info
- Publication number
- JP2023505441A5 JP2023505441A5 JP2022532697A JP2022532697A JP2023505441A5 JP 2023505441 A5 JP2023505441 A5 JP 2023505441A5 JP 2022532697 A JP2022532697 A JP 2022532697A JP 2022532697 A JP2022532697 A JP 2022532697A JP 2023505441 A5 JP2023505441 A5 JP 2023505441A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025141835A JP2025172864A (ja) | 2019-12-03 | 2025-08-28 | 最適化されたｇｉｐペプチド類縁体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2019/083506 WO2020115048A1 (en) | 2018-12-03 | 2019-12-03 | Modified gip peptide analogues |
| EPPCT/EP2019/083506 | 2019-12-03 | ||
| EP20179259 | 2020-06-10 | ||
| EP20179259.5 | 2020-06-10 | ||
| PCT/EP2020/084487 WO2021110845A1 (en) | 2019-12-03 | 2020-12-03 | Optimized gip peptide analogues |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025141835A Division JP2025172864A (ja) | 2019-12-03 | 2025-08-28 | 最適化されたｇｉｐペプチド類縁体 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023505441A JP2023505441A (ja) | 2023-02-09 |
| JP2023505441A5 true JP2023505441A5 (https=) | 2023-12-12 |
| JPWO2021110845A5 JPWO2021110845A5 (https=) | 2023-12-12 |
| JP7788376B2 JP7788376B2 (ja) | 2025-12-18 |
Family
ID=71083547
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022532697A Active JP7788376B2 (ja) | 2019-12-03 | 2020-12-03 | 最適化されたｇｉｐペプチド類縁体 |
| JP2025141835A Pending JP2025172864A (ja) | 2019-12-03 | 2025-08-28 | 最適化されたｇｉｐペプチド類縁体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025141835A Pending JP2025172864A (ja) | 2019-12-03 | 2025-08-28 | 最適化されたｇｉｐペプチド類縁体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250346647A2 (https=) |
| EP (1) | EP4069719A1 (https=) |
| JP (2) | JP7788376B2 (https=) |
| KR (1) | KR20220108064A (https=) |
| AU (1) | AU2020398675A1 (https=) |
| CA (1) | CA3157387A1 (https=) |
| IL (1) | IL293249A (https=) |
| MX (1) | MX2022006737A (https=) |
| WO (1) | WO2021110845A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20240021212A (ko) * | 2021-06-10 | 2024-02-16 | 안타그 테라퓨틱스 에이피에스 | 비만 및 비만-관련 장애의 치료 |
| WO2023139106A2 (en) * | 2022-01-18 | 2023-07-27 | Novo Nordisk A/S | Long-acting gipr antagonists |
| UY40349A (es) * | 2022-07-13 | 2024-01-31 | Hangzhou Zhongmeihuadong Pharmaceutical Co Ltd | Agonista dual de glp-1/gip, método de preparación y uso del mismo |
| WO2025259957A1 (en) * | 2024-06-14 | 2025-12-18 | Eli Lilly And Company | Compositions and methods for improving insulin sensitivity |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0606992A2 (pt) * | 2005-02-11 | 2009-07-28 | Amylin Pharmaceuticals Inc | análogo e polipeptìdeos hìbridos de gip com propriedades selecionáveis |
| US8263545B2 (en) * | 2005-02-11 | 2012-09-11 | Amylin Pharmaceuticals, Inc. | GIP analog and hybrid polypeptides with selectable properties |
| AU2007284365A1 (en) * | 2006-08-17 | 2008-02-21 | Amylin Pharmaceuticals, Inc. | DPP-IV resistant GIP hybrid polypeptides with selectable properties |
| WO2010016936A1 (en) * | 2008-08-07 | 2010-02-11 | Ipsen Pharma S.A.S. | Pharmaceutical compositions of analogues of glucose-dependent insulinotropic polypeptide |
| KR101417873B1 (ko) * | 2008-08-07 | 2014-07-09 | 입센 파마 에스.에이.에스 | 포도당 의존적인 인슐린 분비 자극성 폴리펩타이드의 유사체 |
| JP2011530507A (ja) * | 2008-08-07 | 2011-12-22 | イプセン ファルマ ソシエテ パール アクシオン サンプリフィエ | グルコース依存性インスリン分泌刺激ポリペプチドアナログ |
| JP6228187B2 (ja) * | 2012-05-03 | 2017-11-08 | ジーランド ファーマ アクティーゼルスカブ | Ｇｉｐ−ｇｌｐ−１デュアルアゴニスト化合物及び方法 |
| US10968266B2 (en) * | 2014-09-05 | 2021-04-06 | University Of Copenhagen | GIP peptide analogues |
| PL3630806T3 (pl) * | 2017-05-31 | 2024-05-13 | The University Of Copenhagen | Analogi peptydów gip o długotrwałym działaniu |
| TWI912614B (zh) * | 2017-12-21 | 2026-01-21 | 美商美國禮來大藥廠 | 腸促胰島素(incretin)類似物及其用途 |
| CN121449721A (zh) * | 2018-12-03 | 2026-02-03 | 安泰博医药 | 经修饰的gip肽类似物 |
-
2020
- 2020-12-03 CA CA3157387A patent/CA3157387A1/en active Pending
- 2020-12-03 US US17/776,976 patent/US20250346647A2/en active Pending
- 2020-12-03 EP EP20815874.1A patent/EP4069719A1/en active Pending
- 2020-12-03 AU AU2020398675A patent/AU2020398675A1/en active Pending
- 2020-12-03 KR KR1020227018518A patent/KR20220108064A/ko active Pending
- 2020-12-03 JP JP2022532697A patent/JP7788376B2/ja active Active
- 2020-12-03 WO PCT/EP2020/084487 patent/WO2021110845A1/en not_active Ceased
- 2020-12-03 IL IL293249A patent/IL293249A/en unknown
- 2020-12-03 MX MX2022006737A patent/MX2022006737A/es unknown
-
2025
- 2025-08-28 JP JP2025141835A patent/JP2025172864A/ja active Pending